Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...

Bulk Rename Utility is a lightweight, easy-to-use file renamer. Effortlessly rename multiple files or folders with flexible options—minimal memory use means it runs quietly in the background.

Find the latest on short interest, settlement dates, average share volume, and days to cover for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.